Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.nejm.org › doi › fullCase 22-2020: A 62-Year-Old Woman with Early Breast Cancer during...

   www.nejm.org › doi › full

   1 Ιουλ 2020 · Imaging Studies of the Breast. Pathological Discussion. Dr. Amy Ly: Histologic evaluation of the biopsy specimen revealed invasive ductal carcinoma, grade 2, spanning at least 1.6 cm in greatest...

2. www.nejm.org › doi › fullCase 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer

   www.nejm.org › doi › full

   5 Ιουν 2024 · A 45-year-old woman was evaluated in the oncology clinic of the hospital because of metastatic triple-negative breast cancer that had progressed despite chemotherapy. Management decisions were...

3. www.cancernetwork.com › view › case-1-48-year-old-patient-with-her2-metastaticCase 1: 48-Year-Old Patient With HER2+ Metastatic Breast Cancer

   www.cancernetwork.com › view › case-1-48-year-old-patient-with-her2-metastatic

   • Αποθηκευμένο αντίγραφο

   23 Φεβ 2021 · Cancer Network Around the Practice: Relapsed/Refractory HER2+ Metastatic Breast Cancer. Adam M. Brufsky, MD, PhD: Let’s talk about this case. This is a 48-year-old woman who presented to her primary care physician a number of years ago with a lump in her breast. She had a 4.4-cm left breast mass and 3 palpable axillary lymph nodes.

4. pmc.ncbi.nlm.nih.gov › articles › PMC9189918A case-case analysis of women with breast cancer: predictors of...

   pmc.ncbi.nlm.nih.gov › articles › PMC9189918

   We conducted a case-case analysis of women treated for invasive breast cancer at the University of California San Francisco Breast Care Center (UCSF BCC). This study included only women with a confirmed diagnosis of invasive breast cancer previously undergoing standard mammography screening.

5. pmc.ncbi.nlm.nih.gov › articles › PMC8642036Educational Case: HER-2 Positive Breast Cancer - PMC - PubMed...

   pmc.ncbi.nlm.nih.gov › articles › PMC8642036

   HER-2 positive breast cancers have been found to have a worse overall prognosis than HER-2 negative breast cancers. Population-based studies have shown that overexpression of HER-2 is associated with poorly differentiated, high-grade tumors, high proliferative rates, lymph node involvement, and relative resistance to certain types of ...

6. pmc.ncbi.nlm.nih.gov › articles › PMC7140050Treatment Strategies and Survival Outcomes in Breast Cancer

   pmc.ncbi.nlm.nih.gov › articles › PMC7140050

   For primary breast cancer, Corradini et al. analysed the oncological outcomes of 7565 cases of breast cancer in a case-controlled cohort study comparing breast conserving surgery followed by radiotherapy with mastectomy, showing that the former was associated with better recurrence control and survival, and as such recommended physicians to enco...

7. www.frontiersin.org › journals › oncologyFrontiers | Case report: From negative to positive: a remarkable...

   www.frontiersin.org › journals › oncology

   • Αποθηκευμένο αντίγραφο

   25 Απρ 2024 · Breast cancer is the most common malignant tumor in women, posing a serious threat to women’s health. HER2 has been identified as a key oncogene and prognostic factor in breast cancer. Recent studies have reported inconsistencies in ER, PR, and/or HER2 expression between primary breast tumors and metastatic lesions.